VTGNVistaGen Therapeutics, Inc.Feb 12, 2026Q3 2026
Read transcript →VistaGen Therapeutics, Inc. (VTGN) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$0.26
+12.45%
Mkt Cap $9.89M
VTGNVistaGen Therapeutics, Inc.Feb 12, 2026VTGNVistaGen Therapeutics, Inc.Nov 13, 2025Q2 2026
Read transcript →VTGNVistaGen Therapeutics, Inc.Aug 8, 2025Q1 2026
Read transcript →VTGNVistaGen Therapeutics, Inc.Jun 17, 2025Q4 2025
Read transcript →VTGNVistaGen Therapeutics, Inc.Feb 13, 2025Q3 2025
Read transcript →VTGNVistaGen Therapeutics, Inc.Nov 10, 2024Q2 2025
Read transcript →VTGNVistaGen Therapeutics, Inc.Aug 13, 2024Q1 2025
Read transcript →VTGNVistaGen Therapeutics, Inc.Jun 11, 2024Q4 2024
Read transcript →VTGNVistaGen Therapeutics, Inc.Feb 13, 2024Q3 2024
Read transcript →VTGNVistaGen Therapeutics, Inc.Nov 10, 2023Q2 2024
Read transcript →VTGNVistaGen Therapeutics, Inc.Aug 13, 2023Q1 2024
Read transcript →VTGNVistaGen Therapeutics, Inc.Jun 28, 2023Q4 2023
Read transcript →VTGNVistaGen Therapeutics, Inc.Feb 10, 2023Q3 2023
Read transcript →VTGNVistaGen Therapeutics, Inc.Nov 10, 2022Q2 2023
Read transcript →VTGNVistaGen Therapeutics, Inc.Aug 12, 2022Q1 2023
Read transcript →VTGNVistaGen Therapeutics, Inc.Jun 23, 2022Q4 2022
Read transcript →VTGNVistaGen Therapeutics, Inc.Feb 10, 2022Q3 2022
Read transcript →VTGNVistaGen Therapeutics, Inc.Nov 10, 2021Q2 2022
Read transcript →VTGNVistaGen Therapeutics, Inc.Aug 12, 2021Q1 2022
Read transcript →VTGNVistaGen Therapeutics, Inc.Jun 29, 2021Q4 2021
Read transcript →VTGNVistaGen Therapeutics, Inc.Dec 12, 2007Q4 2007
Read transcript →